(Q33270407)

24 July 2017

title

Macrolide immunomodulation of chronic respiratory diseases (English)

1 reference

24 July 2017

Daniel P Healy

1

1 reference

24 July 2017

publication date

1 January 2007

1 reference

Current infectious disease reports

24 July 2017

published in

1 reference

24 July 2017

volume

9

1 reference

24 July 2017

issue

1

1 reference

24 July 2017

page(s)

7-13

1 reference

Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0016-1

Immunomodulation by macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0016-1

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0016-1

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0016-1

Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis

21 January 2018

1 reference

12 December 2020

The effects of macrolides on inflammatory cells

1 reference

12 December 2020

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors

1 reference

12 December 2020

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease

1 reference

12 December 2020

Antibiotics in asthma

1 reference

12 December 2020

Macrolides for the treatment of chronic sinusitis, asthma, and COPD.

1 reference

12 December 2020

Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma

1 reference

12 December 2020

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

12 December 2020

Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis

1 reference

12 December 2020

Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis

1 reference

12 December 2020

Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.

1 reference

12 December 2020

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

1 reference

12 December 2020

Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages

1 reference

12 December 2020

Clinical implications of the immunomodulatory effects of macrolides on sinusitis.

1 reference

12 December 2020

Macrolides in the treatment of asthma and cystic fibrosis.

1 reference

12 December 2020

Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa

1 reference

12 December 2020

Azithromycin, the multidrug-resistant protein, and cystic fibrosis

1 reference

12 December 2020

Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

1 reference

12 December 2020

Macrolides in cystic fibrosis

1 reference

12 December 2020

Macrolides and airway inflammation in children

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model

1 reference

12 December 2020

Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.

1 reference

12 December 2020

Clinical implications of the immunomodulatory effects of macrolides

1 reference

12 December 2020

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

1 reference

12 December 2020

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis

1 reference

12 December 2020

Immunomodulatory properties of macrolides: overview and historical perspective

1 reference

12 December 2020

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

12 December 2020

Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma

1 reference

12 December 2020

Dose- and time-related effect of troleandomycin on methylprednisolone elimination

1 reference

12 December 2020

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

1 reference

12 December 2020

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

12 December 2020

Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis

1 reference

12 December 2020

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11908-007-0016-1

Identifiers

DOI

1 reference

24 July 2017

1 reference